Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Angel Qin, MD
University of Michigan Health
Clinical Associate Professor
Published Articles (1)
Frontline EGFR-Mutant NSCLC: Navigating an Era of Combination Therapy
May 4, 2026
New frontline therapies are transforming EGFR-mutant NSCLC care. Learn how MARIPOSA, FLAURA2, and emerging biomarker-driven strategies are reshaping treatment selection and survival outcomes.